Terumo BCT spectra optia apheresis system

Closed Pre-Solicitation Posted

Solicitation number
25-005554
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Maryland 20892, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institutes of Health (NIH) Clinical Center's Office of Purchasing and Contracts intends to procure a Terumo BCT Spectra Optia Apheresis System for the Department of Transfusion Medicine. The procurement involves acquiring two complete apheresis systems, which are critical for blood cell collection, therapeutic apheresis, and cell processing. The contract will be a fixed-price sole source purchase order directly with Terumo BCT, located in Lakewood, CO, who is deemed the only source capable of fulfilling the requirement. Interested parties have until May 5, 2025, at 12:00 pm EST to submit capability statements outlining their ability to provide similar products or services. The government will solely determine whether to conduct a competitive procurement based on the received responses, with comments to be submitted electronically to Contract Specialist Emeka Onyejekwe.

The pre-solicitation notice indicates no specific set-aside designation for this procurement. The total equipment order includes two Spectra Optia Apheresis Systems, along with related kits and power cords, with a total quantity of eight individual components. The current equipment has reached the end of its operational lifecycle, with escalating maintenance costs and potential disruptive downtime threatening patient care services. The procurement will be conducted using Federal Acquisition Regulation (FAR) Part 13 - Simplified Acquisition Procedures, which exempts the contract from standard competition requirements. While no specific award value is disclosed, the procurement is driven by the critical need to replace aging medical equipment and ensure uninterrupted, reliable medical procedures at the NIH Clinical Center's Department of Transfusion Medicine.

Notice text

Title:  TERUMO BCT SPECTRA OPTIA APHERESIS SYSTEM

NAICS Code: 334516: Analytical Laboratory Instrument Manufacturing6 1,000

Product Service Code: 6640: Laboratory Equipment and Supplies.

Place of Performance:  Bethesda, MD 20892

POTS: 25-005554

Description

This is a notice of intent, not a request for a quotation. A solicitation document will not be issued, and quotations will not be requested. The National Institutes of Health (NIH), Clinical Center, Office of Purchasing and Contracts on behalf of the The Department of Transfusion Medicine, serves as the clinical laboratory of the Clinical Research Center intends to award a fixed priced sole source purchase order to Terumo BCT located in West Collins Avenue Lakewood, CO 80215USA to Supplies needed Apheresis System. The proposed devices are critical platform for blood cell collection, therapeutic apheresis, and cell.

Description: 

Product                                                                                                   Quantity.                   Catalog #

SPECTRA OPTIA APHERES                                                                        2                               61000

 IDL Filler                                                                                                       2                              703399003

KIT, LANG, OPTIA, US, ENUS                                                                     2                               705244003

Installation Kit                                                                                               2                              610130000

Power Cord Style B, Medical Grade                                                            2                              701271000                                      

Terumo BCT is the Original Equipment Manufacturer of Spectra Optia Apheresis System. The Apheresis system preforms critical function on platform for blood cell collection, therapeutic apheresis, and cell processing at the Department of Transfusion Medicine of Clinical Center. The Spectra Optia Apheresis System is an industry-leading therapeutic apheresis, cell processing, and cell collection platform that allows operators to spend more time focusing on patient care. This advanced system uses continuous-flow centrifugation and optical detection technology, providing operators the ability to perform a wide variety of apheresis procedures on a single platform. The current equipment has reached the end of its operational lifecycle, with escalating maintenance costs and the risk of disruptive downtime threatening patient care services. Replacing the devices will ensure uninterrupted, reliable medical procedures, reduce long-term expenses, and maintain the highest standards of patient care. Therefore, Terumo BCT is the only source capable of fulfilling this requirement.

This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available.  Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.

Interested Parties:

Interested parties capable of providing the same or similar products or services described in this notice may submit a capability statement outlining their capability to perform the described work.  Capability Statements must be received within the time set forth in this synopsis to be considered by the Government. The determination to compete this proposed contract based on responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.

Comments:

Comments to this announcement, referencing this posting number on the email subject line, may be submitted to the CC, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, electronically to the attention of Emeka Onyejekwe, Contract Specialist, Emeka.onyejekwe@nih.gov by the due date May 05th, 2025, 12:00 pm EST and time marked in this notice.  No phone calls will be accepted.

Similar open opportunities

Opportunity Agency Set-aside Responses due
Intent to Sole Source - Medical/Scientific Instruments for the Department of Transfusion Medicine, NIH Clinical Center Bethesda, Maryland 20892, United States · NAICS 334516 National Institutes of Health No set-aside
Combined Synopsis Solicitation- Acquire service ag NAICS 811210 Office of Logisitics and Acquisition Operations No set-aside
Intent to Sole Source - BD FACSCanto II instrument Bethesda, Maryland 20892, United States · NAICS 334516 National Institutes of Health No set-aside
Service Maintenance for MoFlo Astrio AW10012 Bethesda, Maryland 20892, United States · NAICS 811210 Office of Logisitics and Acquisition Operations No set-aside
Notice of Intent to Sole Source – Boston Scientific Maryland 20892, United States · NAICS 339112 NIH Clinical Center No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity